Orthocell jumps as nerve repair tech shows hope for erectile dysfunction post-prostate surgery
Orthocell shares popped +10% as the company reported its flagship nerve repair product, Remplir, is being used by Australian urologists.
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
CTF | is something woth saving | 21/06/08 | 2 | 1.4K | |||
|
|||||||
CTF | round two | 06/03/08 | 2 | 1.4K | |||
|
|||||||
CTF | up 30pc...maybe they found an aids cure | 05/03/08 | 1 | 1.0K | |||
|
|||||||
CTF | quintessentially both aussie and unaussie | 11/02/08 | 1 | 935 | |||
|
|||||||
CTF | ravi vindicated | 29/12/07 | 3 | 1.5K | |||
|
|||||||
CTF | point noted | 14/12/07 | 0 | 483 | |||
|
|||||||
CTF | anyone know if a class action maybe instigated | 12/12/07 | 3 | 1.4K | |||
|
|||||||
CTF | something happening here | 12/10/07 | 0 | 499 | |||
|
See All Discussions